Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement

Links shared publicly online about this topic.

  • 437
    total visits

Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement

newswise.com

Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.

View full resource at newswise.com

Tags: Heart, Heart Disease, Heart Attack, Drug, Anti-Clotting Medication, Plavix, Iscover

  • Share

Most Recently Shared on March 15, 2011 at 8:23 pm By:

newswise newswise

Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient's dosage of th... http://bit.ly/hOcHHY

1 year ago...

Study Examines Outcomes of High-dose Antiplatelet Drug After Stent Placement - Drugs.com MedNews

drugs.com — “CHICAGO, March 15, 2011 Modifying a patient s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient s level of platelet reactivity dView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 16, 2011 at 3:10 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Study Examines Outcomes of High-dose Antiplatelet Drug After Stent Placement: CHICAGO, March 15, 2011 – Mo... http://bit.ly/fKZUzi #drug

1 year ago...

Study examines outcomes of high-dose antiplatelet drug after stent placement

physorg.com — “Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 9:08 pm By:

physorg_health PhysOrg Health News Health News

Study examines outcomes of high-dose antiplatelet drug after stent placement http://tw.physorg.com/219427381

1 year ago...

Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement

newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 15, 2011 at 8:21 pm By:

mednewswise Thom Canalichio Health News

#health news: Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient'... http://bit.ly/hmS7Qs

1 year ago...

Advertisement